Maurizio Botta

Affiliations: 
University of Siena, Italy, Siena, Toscana, Italy 
Google:
"Maurizio Botta"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Riva V, Garbelli A, Brai A, et al. (2020) Unique Domain for a Unique Target: Selective Inhibitors of Host Cell DDX3X to Fight Emerging Viruses. Journal of Medicinal Chemistry
de Souza ACA, Mori M, Sens L, et al. (2020) A chalcone derivative binds a putative allosteric site of YopH: Inhibition of a virulence factor of Yersinia. Bioorganic & Medicinal Chemistry Letters. 30: 127350
Brai A, Riva V, Saladini F, et al. (2020) DDX3X inhibitors, an effective way to overcome HIV-1 resistance targeting host proteins. European Journal of Medicinal Chemistry. 200: 112319
Brai A, Boccuto A, Monti M, et al. (2020) Exploring the Implication of DDX3X in DENV Infection: Discovery of the First-in-Class DDX3X Fluorescent Inhibitor. Acs Medicinal Chemistry Letters. 11: 956-962
Borgini M, Zamperini C, Poggialini F, et al. (2020) Synthesis and Antiproliferative Activity of Nitric Oxide-Donor Largazole Prodrugs. Acs Medicinal Chemistry Letters. 11: 846-851
Malancona S, Mori M, Fezzardi P, et al. (2020) 5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein. Acs Medicinal Chemistry Letters. 11: 766-772
Diukendjieva A, Zaharieva MM, Mori M, et al. (2020) Dual SMO/BRAF Inhibition by Flavonolignans from . Antioxidants (Basel, Switzerland). 9
Iralde-Lorente L, Tassone G, Clementi L, et al. (2020) Identification of phosphate-containing compounds as new inhibitors of 14-3-3/c-Abl protein-protein interaction. Acs Chemical Biology
Batista FAH, Ramos SL, Tassone G, et al. (2020) Discovery of small molecule inhibitors of Hsp90 chaperone. Journal of Enzyme Inhibition and Medicinal Chemistry. 35: 639-649
Humbert N, Kovalenko L, Saladini F, et al. (2020) (Thia)calixarenephosphonic acids as potent inhibitors of the nucleic acid chaperone activity of the HIV-1 nucleocapsid protein with a new binding mode and multi-target antiviral activity. Acs Infectious Diseases
See more...